1. Home
  2. FATE vs SEG Comparison

FATE vs SEG Comparison

Compare FATE & SEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • SEG
  • Stock Information
  • Founded
  • FATE 2007
  • SEG 2024
  • Country
  • FATE United States
  • SEG United States
  • Employees
  • FATE N/A
  • SEG N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • SEG
  • Sector
  • FATE Health Care
  • SEG
  • Exchange
  • FATE Nasdaq
  • SEG NYSE
  • Market Cap
  • FATE 406.5M
  • SEG 362.3M
  • IPO Year
  • FATE 2013
  • SEG N/A
  • Fundamental
  • Price
  • FATE $2.02
  • SEG $30.24
  • Analyst Decision
  • FATE Buy
  • SEG
  • Analyst Count
  • FATE 11
  • SEG 0
  • Target Price
  • FATE $6.89
  • SEG N/A
  • AVG Volume (30 Days)
  • FATE 1.6M
  • SEG 93.9K
  • Earning Date
  • FATE 11-12-2024
  • SEG 11-22-2024
  • Dividend Yield
  • FATE N/A
  • SEG N/A
  • EPS Growth
  • FATE N/A
  • SEG N/A
  • EPS
  • FATE N/A
  • SEG N/A
  • Revenue
  • FATE $13,447,000.00
  • SEG $111,487,000.00
  • Revenue This Year
  • FATE N/A
  • SEG N/A
  • Revenue Next Year
  • FATE N/A
  • SEG N/A
  • P/E Ratio
  • FATE N/A
  • SEG N/A
  • Revenue Growth
  • FATE N/A
  • SEG 36.09
  • 52 Week Low
  • FATE $1.96
  • SEG $22.51
  • 52 Week High
  • FATE $8.83
  • SEG $36.50
  • Technical
  • Relative Strength Index (RSI)
  • FATE 31.10
  • SEG N/A
  • Support Level
  • FATE $2.33
  • SEG N/A
  • Resistance Level
  • FATE $2.58
  • SEG N/A
  • Average True Range (ATR)
  • FATE 0.25
  • SEG 0.00
  • MACD
  • FATE -0.04
  • SEG 0.00
  • Stochastic Oscillator
  • FATE 6.45
  • SEG 0.00

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About SEG SEAPORT ENTERTAINMENT GROUP INC

Seaport Entertainment Group Inc own, operate and develop a unique collection of assets positioned at the intersection of entertainment and real estate. Its objective is to integrate one-of-a-kind real estate assets with a variety of restaurant, retail and leisure offerings to form vibrant mixed-use destinations where customers can work, play and socialize in one cohesive setting. The company has three operating segments: (1) Landlord Operations; (2) Hospitality; and (3) Sponsorships, Events, and Entertainment. Key revenue is generated from Landlord Operations which consists of the company's rental operations.

Share on Social Networks: